Drug shortage: Quinapril Hydrochloride Tablet (QUINAPRIL)
FDA lists 16 presentations as Current. Availability: Unavailable (12), Available (4). Reason: Shortage of an active ingredient; Requirements related to complying with good manufacturing practices. Companies: Solco Healthcare US, LLC, Lupin Pharmaceuticals, Inc., Aurobindo Pharma USA, Chartwell Molecular Holdings LLC.
- Published by source
- 2023-01-19
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Solco Healthcare US, LLC
- Products
- Quinapril Hydrochloride Tablet QUINAPRIL
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Not available. Long-term backorder for all NDCs. No estimated release date at this time.
- Estimated recovery: TBD
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-01-19
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #868 | new | 2026-10-22 | ed1d67bdd318…13753a | faa0f3ee4845…c429b4 |
Chain head: #1094 edf3be25ec2e…478842